Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEX168 and Digoxin Interaction Study in Healthy Adults
NCT02451527Phase 1Completed
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- May 2015
- Primary completion
- Sep 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label trial of polyethylene glycol loxenatide in type 2 diabetes mellitus (T2DM), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Started May 2015; status: completed.
02
Drugs
polyethylene glycol loxenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02451527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02451527.